These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18479696)

  • 1. Catanionic aggregates formed from drugs and lauric or capric acids enable prolonged release from gels.
    Dew N; Bramer T; Edsman K
    J Colloid Interface Sci; 2008 Jul; 323(2):386-94. PubMed ID: 18479696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gel formation in systems composed of drug containing catanionic vesicles and oppositely charged hydrophobically modified polymer.
    Dew N; Edwards K; Edsman K
    Colloids Surf B Biointerfaces; 2009 May; 70(2):187-97. PubMed ID: 19167869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catanionic mixtures involving a drug: a rather general concept that can be utilized for prolonged drug release from gels.
    Bramer T; Dew N; Edsman K
    J Pharm Sci; 2006 Apr; 95(4):769-80. PubMed ID: 16498573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel gel formulations with catanionic aggregates enable prolonged drug release and reduced skin permeation.
    Dew N; Edsman K; Björk E
    J Pharm Pharmacol; 2011 Oct; 63(10):1265-73. PubMed ID: 21899541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of regular solution theory on the release mechanism of catanionic mixtures from gels.
    Bramer T; Frenning G; Gråsjö J; Edsman K; Hansson P
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):214-25. PubMed ID: 19286357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gel formulations containing catanionic vesicles composed of alprenolol and SDS: effects of drug release and skin penetration on aggregate structure.
    Dew N; Edwards K; Eriksson J; Edsman K; Björk E
    Colloids Surf B Biointerfaces; 2012 Jan; 89():53-60. PubMed ID: 21958537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical applications for catanionic mixtures.
    Bramer T; Dew N; Edsman K
    J Pharm Pharmacol; 2007 Oct; 59(10):1319-34. PubMed ID: 17910806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catanionic drug-surfactant mixtures: phase behavior and sustained release from gels.
    Bramer T; Paulsson M; Edwards K; Edsman K
    Pharm Res; 2003 Oct; 20(10):1661-7. PubMed ID: 14620523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants.
    Paulsson M; Edsman K
    Pharm Res; 2001 Nov; 18(11):1586-92. PubMed ID: 11758767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alkyl chain asymmetry on catanionic mixtures of hydrogenated and fluorinated surfactants.
    Blanco E; Rodriguez-Abreu C; Schulz P; Ruso JM
    J Colloid Interface Sci; 2010 Jan; 341(2):261-6. PubMed ID: 19853859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of drug/surfactant catanionic vesicles and their application in sustained drug release.
    Jiang Y; Li F; Luan Y; Cao W; Ji X; Zhao L; Zhang L; Li Z
    Int J Pharm; 2012 Oct; 436(1-2):806-14. PubMed ID: 22871561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catanionic surfactant vesicles for electrostatic molecular sequestration and separation.
    Lioi SB; Wang X; Islam MR; Danoff EJ; English DS
    Phys Chem Chem Phys; 2009 Nov; 11(41):9315-25. PubMed ID: 19830312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructures formed by self-assembly of negatively charged polymer and cationic surfactants.
    Nizri G; Makarsky A; Magdassi S; Talmon Y
    Langmuir; 2009 Feb; 25(4):1980-5. PubMed ID: 19143559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origins of the viscosity peak in wormlike micellar solutions. 1. Mixed catanionic surfactants. A cryo-transmission electron microscopy study.
    Ziserman L; Abezgauz L; Ramon O; Raghavan SR; Danino D
    Langmuir; 2009 Sep; 25(18):10483-9. PubMed ID: 19572608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loading capacity and interaction of DNA binding on catanionic vesicles with different cationic surfactants.
    Xu L; Chen J; Feng L; Dong S; Hao J
    Soft Matter; 2014 Dec; 10(45):9143-52. PubMed ID: 25317547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ripening of catanionic aggregates upon dialysis.
    Michina Y; Carriere D; Mariet C; Moskura M; Berthault P; Belloni L; Zemb T
    Langmuir; 2009 Jan; 25(2):698-706. PubMed ID: 19177643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-induced vesicle aggregation in catanionic surfactant systems: the effects of the headgroup and counterion.
    Yin H; Lin Y; Huang J; Ye J
    Langmuir; 2007 Apr; 23(8):4225-30. PubMed ID: 17371059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous vesicle formation in catanionic mixtures of amino acid-based surfactants: chain length symmetry effects.
    Marques EF; Brito RO; Silva SG; Rodríguez-Borges JE; do Vale ML; Gomes P; Araújo MJ; Söderman O
    Langmuir; 2008 Oct; 24(19):11009-17. PubMed ID: 18720960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrodynamic investigations of ion transport and structural properties in drug-containing gels: dielectric spectroscopy and transient current measurements on catanionic carbopol systems.
    Brohede U; Bramer T; Edsman K; Strømme M
    J Phys Chem B; 2005 Aug; 109(32):15250-5. PubMed ID: 16852931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catanionic vesicles formed with arginine-based surfactants and 1,2-dipalmitoyl-sn-glycero-3-phosphate monosodium salt.
    Lozano N; Pinazo A; La Mesa C; Perez L; Andreozzi P; Pons R
    J Phys Chem B; 2009 May; 113(18):6321-7. PubMed ID: 19402726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.